MEDICAL CHANNEL ASIA

PUBLIC PORTAL

PUBLIC PORTAL

MEDICALLY REVIEWED

HSA approves the first JAK inhibitor for moderate-to-severe atopic dermatitis: baricitinib (Olumiant)

baricitinib olumiant for atopic dermaitis eczema

Disease burden and current treatment landscape
Atopic dermatitis (AD) or atopic eczema is a common inflammatory skin condition that affects 20.8% of children aged 7 to 16 years in Singapore. While many children (about 70%) improve as . . .

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

ear infection asian lady
Ear Infections

Ear infections are a simplified term for Otitis Media, which is an infection of the middle ear. It involves the air-filled space behind the eardrum

Read More »